SCHEMBL7779674

SCHEMBL7779674

N#Cc1c(Cl)ccc([N+](=O)[O-])c1NCC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.51
MAPT P10636 4/20 0.50
VCAM1 P19320 5/20 0.41
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
BRAF P15056 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
FBP1 P09467 1/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
AKR1B1 P15121 1/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3149349 0.83 RAB9A (0.74) RAB9AMAPTVCAM1ALDH1A1TDP1
SCHEMBL3153199 0.82 RAB9A (0.51) RAB9AMAPTVCAM1ALDH1A1TDP1
SCHEMBL8278796 0.81 RAB9A (0.47) RAB9AMAPTVCAM1ALDH1A1MEN1
SCHEMBL894368 0.77 VCAM1 (0.47) RAB9AMAPTVCAM1TDP1BRAF
SCHEMBL3046272 0.76 MAPT (0.55) RAB9AMAPTALDH1A1TDP1MEN1
SCHEMBL25352613 0.74 VCAM1 (0.44) RAB9AMAPTVCAM1ALDH1A1TDP1
SCHEMBL3948505 0.74 MAPT (0.51) MAPTALDH1A1TDP1MEN1KMT2A
SCHEMBL8313813 0.73 VCAM1 (0.56) RAB9AMAPTVCAM1ALDH1A1TDP1
SCHEMBL7860943 0.72 VCAM1 (0.51) RAB9AMAPTVCAM1ALDH1A1TDP1
SCHEMBL894816 0.72 TDP1 (0.60) RAB9AMAPTVCAM1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed